# BridgeBio seesaws after settlement in Pfizer Vyndamax patent dispute (update)

*biotech · news · 2026-04-28 · Seeking Alpha*

## Key points

- BridgeBio and Pfizer have settled a patent dispute over the drug Vyndamax.
- BridgeBio's shares initially rose 11% but reversed to a 1.3% loss after the news.
- Pfizer's shares declined by 0.7% following disclosure of the settlement.
- A court filing confirmed the resolution of the generic patent case.

**Companies:** Pfizer, BridgeBio Pharma
**Countries:** United States

[Read the full story on Seeking Alpha](https://seekingalpha.com/news/4580634-bridgebio-gains-after-settlement-in-pfizer-vyndamax-patent-dispute)

---

Canonical: https://newsio.io/n/cb6c4f8c-d255-4ac1-82cc-058f1ca0c628/bridgebio-seesaws-after-settlement-in-pfizer-vyndamax-patent-dispute-update
Summarized by Newsio from Seeking Alpha. https://newsio.io/how-it-works